Jianbo Wu

Prof. Jianbo Wu

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2023 in Placenta
Verified
Journal Article
Closed access
LHLidan He
Lidan He
XWXiuyan Wu
Xiuyan Wu
FZFeng Zhan
Feng Zhan
XLXuemei Li
Xuemei Li
JWJianbo Wu
Jianbo Wu

22 July 2019 in Open Life Sciences
Verified
Journal Article
Open access
PDF file
HLHe Lidan
He Lidan
JWJianbo Wu
Jianbo Wu
GLGao Liqin
Gao Liqin
HJHu Jifen
Hu Jifen
LLLu Lin
Lu Lin
WXWu Xiuyan
Wu Xiuyan
Objective: The aim of this study was to investigate the diagnostic efficacy of thrombelastography (TEG) in patients with preeclampsia.Methods: One hundred and seventeen pregnant women were recruited from Department of Obstetrics and Gynecology of 1st affiliated Hospital of Fujian Medical University. Of the 117 patients, 59 were normal late gestation (control group), 32 were mild preeclampsia and other 26 cases were severe preeclampsia. All the patients were received thrombelastography (including: K time, Reaction time, Clot angel, MA value, CI value) and blood coagulation examination (including: PT, APTT, Fib, TT, D-dimer and AT-III).Results: The R time, K time, Coagulation Index value and Clot Angle in preeclampsia group were significant different between control and preeclampsia groups with statistical difference (p<0.05). Moreover, the R and K time value in severe preeclampsia group were significant higher than those of control groups (p<0.05); however, the Coagulation Index value and Clot Angle in severe preeclampsia group were significant higher than those of mild preeclampsia group with statistical difference (p0.05).Conclusion: TEG provides more accurate information in monitoring the blood coagulation of preeclampsia patients and can be used as a reliable marker for assessing the severity of preeclampsia.

4 July 2023 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
LHLidan He
Lidan He
FZFeng Zhan
Feng Zhan
LLLin Lu
Lin Lu
XZXia Zhang
Xia Zhang
JWJianbo Wu
Jianbo Wu
Background: Preeclampsia (PE) is a serious pregnancy complication that can adversely affect the mother and fetus. Necroptosis is a recently discovered new form of programmed cell death involved in the pathological process of various pregnancy complications. Our study aimed to identify the necroptosis-related differentially expressed genes (NRDEGs), create a diagnosis model and related disease subtypes model based on these genes, and further investigate their relationship with immune infiltration. Methods: In this study, we identified NRDEGs by analyzing data from various databases, including Molecular Signatures, GeneCards, and Gene Expression Omnibus (GEO). Using minor absolute shrinkage and selection operator (LASSO) and logistic Cox regression analysis, we developed a novel PE diagnosis model based on NRDEGs. Furthermore, we developed PE subtype models using consensus clustering analysis based on key gene modules screened out by weighted correlation network analysis (WGCNA). Finally, we identified the difference in immune infiltration between the PE and control groups as well as between both PE subtypes by analyzing the immune cell infiltration across combined datasets and PE datasets. Results: Our study discovered that the necroptosis pathway was significantly enriched and active in PE samples. We identified nine NRDEGs that involved in this pathway, including BRAF, PAWR, USP22, SYNCRIP, KRT86, MERTK, BAP1, CXCL5, and STK38. Additionally, we developed a diagnostic model based on a regression model including six NRDEGs and identified two PE subtypes: Cluster1 and Cluster2, based on key module genes. Furthermore, correlation analysis showed that the abundance of immune cell infiltration was related to necroptosis genes and PE disease subtypes. Conclusion: According to the present study, necroptosis is a phenomenon that occurs in PE and is connected to immune cell infiltration. This result suggests that necroptosis and immune-related factors may be the underlying mechanisms of PE pathophysiology. This study opens new avenues for future research into PE's pathogenesis and treatment options.

6 July 2022 in Placenta
Verified
Journal Article
Closed access
LHLidan He
Lidan He
XWXiuyan Wu
Xiuyan Wu
XZXia Zhang
Xia Zhang
XLXuemei Li
Xuemei Li
XLXin Lin
Xin Lin
JWJianbo Wu
Jianbo Wu

21 February 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
LHLidan He
Lidan He
FZFeng Zhan
Feng Zhan
XLXuemei Li
Xuemei Li
HYHuijuan Yang
Huijuan Yang
JWJianbo Wu
Jianbo Wu
Preeclampsia (PE) is a severe pregnancy complication with limited early diagnostic and therapeutic options. Ferroptosis, an iron-dependent cell death pathway, has emerged as a potential mechanism in PE pathogenesis. This study investigated ferroptosis-related genes (FRGs) in PE to identify diagnostic biomarkers and therapeutic targets. Differentially expressed genes were identified from GEO databases and intersected with FRGs. Hub genes were selected using RandomForest and LASSO algorithms. Their diagnostic potential was evaluated through ROC analysis. Regulatory networks were constructed using transcription factors, microRNAs and potential drug targets. Hub gene expression was validated through immunohistochemistry, Western blot, and RT-qPCR in placental tissues and hypoxic trophoblasts. We identified 25 ferroptosis-related differentially expressed genes enriched in ferroptosis and HIF-1 pathways. Four hub genes (NDRG1, P4HA1, LDHA, and IDO1) showed high diagnostic efficiency (AUC=0.9182). Immune cell analysis revealed altered levels of plasma cells, CD8+ T cells, Tregs, monocytes, and M2 macrophages in PE, correlating significantly with hub gene expression. We identified 84 mRNA-miRNA and 119 mRNA-TF interactions. Among 19 potential drugs, Tetrahydro-NAD showed promising targeting potential. Experimental validation confirmed elevated expression of NDRG1, P4HA1, and LDHA, and decreased IDO1 in PE tissues and hypoxic conditions. This study identified four FRGs as potential PE biomarkers and therapeutic targets, providing new insights into PE pathogenesis through integrated bioinformatics and experimental validation. These findings may facilitate early PE diagnosis and treatment development.

3 October 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
XWXiuyan Wu
Xiuyan Wu
XLXuemei Li
Xuemei Li
YWYaoru Wu
Yaoru Wu
HYHuijuan Yang
Huijuan Yang
JWJianbo Wu
Jianbo Wu
LHLidan He
Lidan He
Preeclampsia (PE) is a serious hypertensive complication during pregnancy characterized by immune dysregulation and vascular dysfunction, however, the precise molecular mechanisms and effective therapeutic strategies remain unclear. This study focused on identifying immune-related differentially expressed genes (IRDEGs) in PE, investigate their biological significance and regulatory networks, and establish robust diagnostic models through integrated bioinformatics and experimental analyses. Gene expression data from the GSE75010 dataset were analyzed utilizing the R-based "limma" package to determine differentially expressed genes (DEGs), which were intersected with immune-related genes (IRGs) to obtain IRDEGs. Functional enrichment was assessed using Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Disease Ontology (DO) analyses. Hub genes were identified via Random Forest (RF) and LASSO regression algorithms, and their diagnostic performance was assessed via receiver operating characteristic (ROC) curve evaluation in both training (GSE75010) and validation (GSE44711) cohorts. Immune cell composition and its association with hub genes were explored using CIBERSORT. Regulatory networks, including protein–protein interaction (PPI), mRNA-miRNA and mRNA-TF interactions, were constructed using ENCORI and CHIPBase databases. Analysis of potential pharmaceutical-gene interactions was performed via DGIdb platform interrogation, followed by experimental validation in placental tissue and trophoblast cells. We identified 354 DEGs, including 49 IRDEGs (25 upregulated and 24 downregulated). Enrichment evaluation demonstrated that IRDEGs were associated with PI3K-AKT signaling, chemokine signaling, and cytokine-cytokine receptor interaction. DO analysis linked IRDEGs to PE, cardiovascular diseases, and reproductive disorders. Four hub genes (FLT1, PIK3CB, KLRD1, and APLN) were identified as PE biomarkers based on their connectivity in the PPI network and performance in machine learning models. The RF-based diagnostic model demonstrated excellent discrimination ability with AUCs of 0.9468 (training cohort) and 0.9844 (validation cohort). Immune infiltration analysis revealed higher levels of eosinophils, plasma cells, and CD8 + T cells in PE, while monocytes and M2 macrophages were reduced. Notably, hub genes showed distinct correlations with immune cell subtypes, such as the positive association observed between FLT1 and plasma cells, contrasting with the inverse relationship documented between APLN and CD8 + T cells. Network analysis identified 128 mRNA-miRNA and 31 mRNA-TF interaction pairs. Drug-gene interaction analysis showed cyclooxygenase inhibitors, such as aspirin, targeted APLN, while TNF-α inhibitors, such as etanercept, targeted KLRD1. Experimental validation confirmed consistent expression trends across clinical specimens and in vitro models: FLT1 and PIK3CB were significantly upregulated while KLRD1 and APLN were significantly downregulated in both preeclamptic placental tissues and hypoxia-exposed trophoblast cells. Our study identified four hub IRDEGs that may serve as potential diagnostic indicators and therapeutic targets for PE. These findings suggest an important role of immune dysregulation in PE pathogenesis and offer new perspectives for treatment strategies. By integrating computational predictions with experimental evidence, our work contributes to the foundation for future clinical applications, though further research including early-stage PE is needed to validate these observations.